ARCHIVES

Phase III Kyprolis Trial Fails OS Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 37 No. 8 | August 29, 2014

Download PDF Visit The Full Archive

Related Articles

South African Investigator Bezwoda Admits Falsifying Data In High-Dose Chemo Study.

February 11, 2000

Hatfield, Kennedy Bill would Establish Panel for Clinical Research

February 16, 1996

Tafinlar Subgroup Data Shows Median OS of 20 Months

October 31, 2014

Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer

January 25, 2008

Search Committee Sends Short List For NCI Director To HHS, White House

April 7, 1995

Pennsylvania Issues RFPs For Cancer Control Program

October 21, 1983